285 related articles for article (PubMed ID: 31681609)
1. Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal Cancer.
Li S; Dong D; Geng J; Zhu X; Shi C; Zhang Y; Wang H; Zhou S; Wu H; Cai Y; Li Y; Wang W
Front Oncol; 2019; 9():1080. PubMed ID: 31681609
[No Abstract] [Full Text] [Related]
2. Comparison of survival and prognostic factors in patients treated with stereotactic body radiotherapy for oligometastases or oligoprogression.
Pembroke CA; Fortin B; Kopek N
Radiother Oncol; 2018 Jun; 127(3):493-500. PubMed ID: 29735409
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
König L; Häfner MF; Katayama S; Koerber SA; Tonndorf-Martini E; Bernhardt D; von Nettelbladt B; Weykamp F; Hoegen P; Klüter S; Susko MS; Debus J; Hörner-Rieber J
Radiat Oncol; 2020 Feb; 15(1):30. PubMed ID: 32019553
[TBL] [Abstract][Full Text] [Related]
4. [Stereotactic body radiation therapy for patients with lung and liver oligometastases from colorectal cancer: a phase Ⅱ trial].
Lei JQ; Liu WY; Tang Y; Tang Y; Li N; Ren H; Yihebali C; Sun YK; Zhang W; Bi XY; Zhao JJ; Fang H; Lu NN; Zhou AP; Wang SL; Song YW; Liu YP; Chen B; Qi SN; Cai JQ; Li YX; Jin J
Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):282-290. PubMed ID: 35316879
[No Abstract] [Full Text] [Related]
5. Stereotactic body radiotherapy prolongs the progression-free survival and delays the change of systemic therapy regimen in patients with lung oligoprogressive metastatic colorectal cancer.
Li S; Dong D; Geng J; Zhu X; Shi C; Zhang Y; Wang H; Zhou S; Wu H; Cai Y; Li Y; Wang W
Asia Pac J Clin Oncol; 2022 Apr; 18(2):e64-e72. PubMed ID: 33629479
[TBL] [Abstract][Full Text] [Related]
6. Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma.
Yamamoto T; Niibe Y; Matsumoto Y; Onishi H; Aoki M; Nishikawa A; Oh RJ; Shintani T; Yahara K; Ozaki M; Manabe Y; Jingu K
J Radiat Res; 2020 Nov; 61(6):935-944. PubMed ID: 32940330
[TBL] [Abstract][Full Text] [Related]
7. The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases.
Andratschke N; Alheid H; Allgäuer M; Becker G; Blanck O; Boda-Heggemann J; Brunner T; Duma M; Gerum S; Guckenberger M; Hildebrandt G; Klement RJ; Lewitzki V; Ostheimer C; Papachristofilou A; Petersen C; Schneider T; Semrau R; Wachter S; Habermehl D
BMC Cancer; 2018 Mar; 18(1):283. PubMed ID: 29534687
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiotherapy for distant metastases to the head and neck.
Mutsaers A; Abugharib A; Poon I; Loblaw J; Bayley A; Zhang L; Chin L; Galapin M; Erler D; Sahgal A; Higgins K; Enepekides D; Eskander A; Karam I
Support Care Cancer; 2024 Mar; 32(4):230. PubMed ID: 38488881
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Stereotactic Body Radiotherapy for Metastatic Colorectal Cancer With Oligometastases, Oligoprogression, or Local Control of Dominant Tumors.
Ji X; Zhao Y; Zhu X; Shen Z; Li A; Chen C; Chu X
Front Oncol; 2020; 10():595781. PubMed ID: 33585211
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of extra-cranial stereotactic body radiotherapy for metastatic breast cancer: Treatment indication matters.
Tan H; Cheung P; Louie AV; Myrehaug S; Niglas M; Atenafu EG; Chu W; Chung HT; Poon I; Sahgal A; Soliman H
Radiother Oncol; 2021 Aug; 161():159-165. PubMed ID: 34119585
[TBL] [Abstract][Full Text] [Related]
12. Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer.
Xu B; Zhao X; Chen D; Zhao W; Wang X; Ding C; Yuan Z; Zhang H
BMC Cancer; 2023 Jan; 23(1):73. PubMed ID: 36681809
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary oligometastases treated by stereotactic body radiation therapy (SBRT): a single institution's experience.
Chai G; Yin Y; Zhou X; Hu Q; Lv B; Li Z; Shi M; Zhao L
Transl Lung Cancer Res; 2020 Aug; 9(4):1496-1506. PubMed ID: 32953521
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy for pulmonary oligometastases: a monoinstitutional analysis of clinical outcomes and potential prognostic factors.
Cuccia F; Mazzola R; Figlia V; Giaj-Levra N; Nicosia L; Ricchetti F; Rigo M; Attinà G; Vitale C; Pastorello E; Ruggieri R; Alongi F
Strahlenther Onkol; 2022 Oct; 198(10):934-939. PubMed ID: 35499694
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiation therapy for abdominal and pelvic oligometastases: Dosimetric targets for safe and effective local control.
Rwigema JM; King C; Wang PC; Kamrava M; Kupelian P; Steinberg ML; Lee P
Pract Radiat Oncol; 2015; 5(3):e183-e191. PubMed ID: 25413386
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy for colorectal lung oligometastases: preliminary single-institution results.
Carvajal C; Navarro-Martin A; Cacicedo J; Ramos R; Guedea F
J BUON; 2015; 20(1):158-65. PubMed ID: 25778311
[TBL] [Abstract][Full Text] [Related]
17. High dose stereotactic body radiotherapy using three fractions for colorectal oligometastases.
Bae SH; Kim MS; Cho CK; Kang JK; Kang HJ; Kim YH; Shin US; Moon SM; Lee DH
J Surg Oncol; 2012 Aug; 106(2):138-43. PubMed ID: 22297789
[TBL] [Abstract][Full Text] [Related]
18. A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer.
Wang X; Zamdborg L; Ye H; Grills IS; Yan D
BMC Cancer; 2018 Oct; 18(1):962. PubMed ID: 30305131
[TBL] [Abstract][Full Text] [Related]
19. Analyses of the local control of pulmonary Oligometastases after stereotactic body radiotherapy and the impact of local control on survival.
Yamamoto T; Niibe Y; Aoki M; Shintani T; Yamada K; Kobayashi M; Yamashita H; Ozaki M; Manabe Y; Onishi H; Yahara K; Nishikawa A; Katsui K; Oh RJ; Terahara A; Jingu K
BMC Cancer; 2020 Oct; 20(1):997. PubMed ID: 33054721
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy.
Sharma A; Duijm M; Oomen-de Hoop E; Aerts JG; Verhoef C; Hoogeman M; Nuyttens JJ
Acta Oncol; 2018 Aug; 57(8):1031-1037. PubMed ID: 29488414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
